Log in

RedHawk Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $0.00
50-Day Range
MA: $0.01
52-Week Range
Now: $0.00
Volume30.62 million shs
Average Volume11.87 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
RedHawk Holdings Corp., through its subsidiaries, engages in sale and distribution of medical devices, and sale of branded generic pharmaceutical drugs primarily in the United States and the United Kingdom. It operates in three segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. The company manufactures and sells sharps and needle destruction devices; carotid artery digital non-contact thermometers; and Centri Controlled Entry System, a full body X-ray scanners. It also distributes WoundClot, a bleeding control solution; Thermofinder FS-700 Pro (professional model) and FS-700 (retail model) digital non-contact thermometers; and Zonis, an antimicrobial ionic silver calcium catheter dressing with wound healing and hemostatic properties. The company serves retail pharmacies, hospitals, physicians' offices, private and public healthcare clinics, corrections facilities, schools, veterinary clinics, emergency services, and long term care facilities. In addition, it is involved in the commercial real estate investment and leasing activities; and provision of debt placement services and other specialized financial services. The company was formerly known as Independence Energy Corp. and changed its name to RedHawk Holdings Corp. in October 2015. RedHawk Holdings Corp. was incorporated in 2005 and is headquartered in Lafayette, Louisiana.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.62 out of 5 stars

Industry, Sector and Symbol

Industry Real Estate Services
Current SymbolOTCMKTS:IDNG
Phone(337) 269-5933



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IDNG News and Ratings via Email

Sign-up to receive the latest news and ratings for IDNG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

RedHawk (OTCMKTS:IDNG) Frequently Asked Questions

How has RedHawk's stock been impacted by COVID-19?

RedHawk's stock was trading at $0.0073 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IDNG stock has decreased by 67.1% and is now trading at $0.0024.
View which stocks have been most impacted by COVID-19

Who are some of RedHawk's key competitors?

What other stocks do shareholders of RedHawk own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RedHawk investors own include Western Refining Logistics (WNRL), Unigold (UGD) and China Biologic Products (CBPO).

Who are RedHawk's key executives?

RedHawk's management team includes the following people:
  • Mr. G. Darcy Klug, Chairman, CFO & Corp. Sec. (Age 67)
  • Mr. Thomas J. Concannon, CEO & Director (Age 65)
  • Mr. Edward P. Crowley, Pres of Redhawk Financial Services, LLc

What is RedHawk's stock symbol?

RedHawk trades on the OTCMKTS under the ticker symbol "IDNG."

How do I buy shares of RedHawk?

Shares of IDNG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is RedHawk's stock price today?

One share of IDNG stock can currently be purchased for approximately $0.00.

What is RedHawk's official website?

The official website for RedHawk is www.independenceenergycorp.com.

How can I contact RedHawk?

RedHawk's mailing address is 3753 Pennridge Dr, BRIDGETON, MO 63044-1226, United States. The company can be reached via phone at (337) 269-5933.

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.